Lonza Group Ag Revenue 2012-2024 | LZAGY
Lonza Group Ag annual/quarterly revenue history and growth rate from 2012 to 2024. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sales of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
- Lonza Group Ag revenue for the quarter ending December 31, 2024 was $0M, a 0% increase year-over-year.
- Lonza Group Ag revenue for the twelve months ending December 31, 2024 was $0M, a 0% increase year-over-year.
- Lonza Group Ag annual revenue for 2024 was $7.467B, a 0.2% decline from 2023.
- Lonza Group Ag annual revenue for 2023 was $7.482B, a 14.74% increase from 2022.
- Lonza Group Ag annual revenue for 2022 was $6.521B, a 10.19% increase from 2021.
| Lonza Group Ag Annual Revenue (Millions of US $) |
|
|---|---|
| 2024 | $7,467 |
| 2023 | $7,482 |
| 2022 | $6,521 |
| 2021 | $5,918 |
| 2020 | $4,808 |
| 2019 | $5,958 |
| 2017 | $5,188 |
| 2016 | $4,195 |
| 2015 | $3,957 |
| 2014 | $3,983 |
| 2013 | $3,869 |
| 2012 | $4,188 |
| 2011 | $3,048 |
| Lonza Group Ag Quarterly Revenue (Millions of US $) |
|
|---|---|
| 2024-12-31 | |
| 2024-06-30 | |
| 2023-12-31 | |
| 2023-06-30 | |
| 2022-12-31 | |
| 2022-06-30 | |
| 2021-12-31 | |
| 2021-06-30 | |
| 2020-12-31 | |
| 2020-06-30 | |
| 2019-12-31 | |
| 2019-06-30 | |
| 2018-12-31 | |
| 2018-06-30 | |
| 2017-12-31 | |
| 2017-06-30 | |
| 2016-12-31 | |
| 2016-06-30 | |
| 2015-12-31 | |
| 2015-06-30 | |
| 2014-12-31 | |
| 2014-06-30 | |
| 2013-12-31 | |
| 2013-06-30 | |
| 2012-12-31 | |
| 2012-06-30 | |
| 2011-12-31 | |
| 2011-06-30 | |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $51.916B | $7.468B |
| Lonza Group AG operates as a supplier to the pharmaceutical, healthcare and life-science industries. The Company divides its activities into four divisions: Life Science Ingredients; Microbial Control; Custom Manufacturing, and Bioscience. The company's Life Science Ingredients segment produces nutrition ingredients for applications in nutrition (food, feed and pharmaceutical application) and chemical intermediates for the agricultural industry. The Microbial Control division focuses on five areas: hygiene, wood protection, water treatment, oil/gas applications, and industrial preservation and comprises products ranging from disinfectants to household cleaning products. The Custom Manufacturing division comprises products used in pharmaceuticals sector. The Bioscience division comprises bioscience products, including cell culture and molecular biology tools for research, tests for microbial detection, and media used in the production of therapeutics. Lonza Group AG is headquartered in Basel, Switzerland. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $237.401B | 28.55 |
| Boston Scientific (BSX) | United States | $145.814B | 36.50 |
| Stryker (SYK) | United States | $145.229B | 30.37 |
| EssilorLuxottica (ESLOY) | France | $130.605B | 0.00 |
| Medtronic (MDT) | Ireland | $113.492B | 16.09 |
| Haleon (HLN) | United Kingdom | $49.556B | 28.23 |
| ResMed (RMD) | United States | $36.981B | 27.78 |
| Agilent Technologies (A) | United States | $33.778B | 22.02 |
| GE HealthCare Technologies (GEHC) | United States | $33.476B | 15.89 |
| Terumo (TRUMY) | Japan | $27.213B | 35.35 |
| Koninklijke Philips (PHG) | Netherlands | $22.201B | 15.96 |
| Insulet (PODD) | United States | $21.367B | 83.87 |
| Zimmer Biomet Holdings (ZBH) | United States | $18.451B | 11.85 |
| Baxter (BAX) | United States | $16.093B | 12.02 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $13.187B | 0.00 |
| Sunny Optical Technology (SNPTF) | China | $9.076B | 0.00 |
| Demant (WILYY) | Denmark | $8.854B | 0.00 |
| Bio-Rad Laboratories (BIO) | United States | $6.325B | 22.01 |
| Lantheus Holdings (LNTH) | United States | $5.545B | 13.99 |
| Prestige Consumer Healthcare (PBH) | United States | $4.207B | 18.80 |
| Perrigo (PRGO) | Ireland | $3.746B | 9.49 |
| Shandong Weigao Medical Polymer (SHWGF) | China | $3.459B | 0.00 |
| Haemonetics (HAE) | United States | $3.428B | 15.61 |
| ICU Medical (ICUI) | United States | $3.258B | 24.02 |
| Envista Holdings (NVST) | United States | $3.198B | 26.58 |
| GN Store Nord (GNNDY) | Denmark | $2.319B | 19.20 |
| QuidelOrtho (QDEL) | United States | $2.021B | 13.90 |
| LeMaitre Vascular (LMAT) | United States | $1.839B | 41.10 |
| AtriCure (ATRC) | United States | $1.600B | 0.00 |
| Acuren (TIC) | United States | $1.308B | 0.00 |
| Neogen (NEOG) | United States | $1.220B | 15.61 |
| AdaptHealth (AHCO) | United States | $1.187B | 12.05 |
| BioLife Solutions (BLFS) | United States | $1.107B | 0.00 |
| Green Thumb Industries (GTBIF) | United States | $1.061B | 23.86 |
| Phibro Animal Health (PAHC) | United States | $0.993B | 12.70 |
| Kestra Medical Technologies (KMTS) | United States | $0.963B | 0.00 |
| InMode (INMD) | Israel | $0.888B | 8.95 |
| CeriBell (CBLL) | United States | $0.657B | 0.00 |
| Evolus (EOLS) | United States | $0.656B | 0.00 |
| Capricor Therapeutics (CAPR) | United States | $0.637B | 0.00 |
| Owens & Minor (OMI) | United States | $0.616B | 5.11 |
| Maravai LifeSciences Holdings (MRVI) | United States | $0.576B | 0.00 |
| Curaleaf Holdings (CURLF) | Canada | $0.547B | 0.00 |
| Valneva SE (VALN) | France | $0.523B | 0.00 |
| Tilray Brands (TLRY) | Canada | $0.419B | 0.00 |
| Surmodics (SRDX) | United States | $0.416B | 0.00 |
| SNDL (SNDL) | Canada | $0.355B | 0.00 |
| VAREX IMAGING (VREX) | United States | $0.351B | 12.92 |
| Aurora Cannabis (ACB) | Canada | $0.342B | 60.90 |
| SEMPERIT AG HLD (SEIGY) | Austria | $0.329B | 0.00 |
| Canopy Growth (CGC) | Canada | $0.281B | 0.00 |
| Viemed Healthcare (VMD) | United States | $0.268B | 22.60 |
| Sanuwave Health (SNWV) | United States | $0.265B | 0.00 |
| Cerus (CERS) | United States | $0.262B | 0.00 |
| ZimVie (ZIMV) | United States | $0.258B | 11.75 |
| Sanara MedTech (SMTI) | United States | $0.255B | 0.00 |
| Cresco Labs (CRLBF) | United States | $0.251B | 0.00 |
| Quanterix (QTRX) | United States | $0.240B | 0.00 |
| OraSure Technologies (OSUR) | United States | $0.219B | 0.00 |
| Biote (BTMD) | United States | $0.216B | 6.08 |
| Brainsway (BWAY) | Israel | $0.216B | 57.10 |
| TriSalus Life Sciences (TLSI) | United States | $0.208B | 0.00 |
| Omeros (OMER) | United States | $0.208B | 0.00 |
| Organigram Global (OGI) | Canada | $0.197B | 0.00 |
| High Tide (HITI) | Canada | $0.189B | 0.00 |
| Utah Medical Products (UTMD) | United States | $0.186B | 15.18 |
| Verano Holdings (VRNOF) | United States | $0.180B | 0.00 |
| Exagen (XGN) | United States | $0.149B | 0.00 |
| Vireo Growth (VREOF) | United States | $0.143B | 0.00 |
| FitLife Brands (FTLF) | United States | $0.134B | 16.51 |
| Jin Medical (ZJYL) | China | $0.109B | 0.00 |
| MacroGenics (MGNX) | United States | $0.098B | 0.00 |
| Veru (VERU) | United States | $0.096B | 0.00 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.092B | 0.00 |
| Fonar (FONR) | United States | $0.090B | 11.60 |
| Quipt Home Medical (QIPT) | United States | $0.089B | 0.00 |
| TerrAscend (TSNDF) | Canada | $0.077B | 0.00 |
| Agape ATP (ATPC) | $0.077B | 0.00 | |
| InterCure (INCR) | Israel | $0.067B | 0.00 |
| Cytosorbents (CTSO) | United States | $0.067B | 0.00 |
| Apyx Medical (APYX) | United States | $0.065B | 0.00 |
| Zynex (ZYXI) | United States | $0.063B | 0.00 |
| ImmuCell (ICCC) | United States | $0.058B | 0.00 |
| Jushi Holdings (JUSHF) | United States | $0.057B | 0.00 |
| Modular Medical (MODD) | United States | $0.043B | 0.00 |
| Nephros (NEPH) | United States | $0.043B | 57.29 |
| United-Guardian (UG) | United States | $0.038B | 13.02 |
| Rockwell Medical (RMTI) | United States | $0.033B | 0.00 |
| Cellectar Biosciences (CLRB) | United States | $0.020B | 0.00 |
| Allurion Technologies (ALUR) | United States | $0.019B | 0.00 |
| Safety Shot (SHOT) | United States | $0.018B | 0.00 |
| Flora Growth (FLGC) | United States | $0.018B | 0.00 |
| INLIF (INLF) | $0.013B | 0.00 | |
| Meihua Medical Technologies (MHUA) | China | $0.012B | 0.00 |
| Trinity Biotech (TRIB) | Ireland | $0.012B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.008B | 0.00 |
| IM Cannabis (IMCC) | Canada | $0.006B | 0.00 |
| Senestech (SNES) | United States | $0.005B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.003B | 0.00 |
| Akanda (AKAN) | Canada | $0.002B | 0.00 |
| Sharps Technology (STSS) | United States | $0.000B | 0.00 |
| InVivo Therapeutics Holdings (NVIVQ) | United States | $0.000B | 0.00 |